The Enterprise Value as of December 2024 (TTM) for Diffusion Pharmaceuticals Inc. (DFFN) is 10.58M

According to Diffusion Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.58M. This represents a change of -89.90% compared to the average of 104.70M of the last 4 quarters.

Diffusion Pharmaceuticals Inc. (DFFN) Historical Enterprise Value (quarterly & annually)

How has DFFN Enterprise Value performed in the past?

The mean historical Enterprise Value of Diffusion Pharmaceuticals Inc. over the last ten years is 12.19M. The current 10.58M Enterprise Value has changed 8.58% with respect to the historical average. Over the past ten years (40 quarters), DFFN's Enterprise Value was at its highest in in the March 2024 quarter at 133.70M. The Enterprise Value was at its lowest in in the December 2014 quarter at -21883887.00.

Diffusion Pharmaceuticals Inc. (DFFN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Diffusion Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Diffusion Pharmaceuticals Inc. (DFFN) Average Enterprise Value

How has DFFN Enterprise Value performed in the past?

The current Enterprise Value of Diffusion Pharmaceuticals Inc. (DFFN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Diffusion Pharmaceuticals Inc. (DFFN) Enterprise Value vs. Peers

How is DFFN’s Enterprise Value compared to its peers?

Diffusion Pharmaceuticals Inc.’s Enterprise Value is greater than Bio-Path Holdings, Inc. (4.59M), less than Catalyst Biosciences, Inc. (1.05B), less than Capricor Therapeutics, Inc. (568.49M), greater than NextCure, Inc. (3.24M), less than Tonix Pharmaceuticals Holding Corp. (54.84M), less than Jaguar Health, Inc. (32.45M), less than Acasti Pharma Inc. (14.78M), less than iBio, Inc. (14.98M), less than Pulmatrix, Inc. (0), greater than Akari Therapeutics, Plc (10.55M), greater than Soleno Therapeutics, Inc. (10.29M), less than Cellectar Biosciences, Inc. (1.88B), greater than Monopar Therapeutics Inc. (-22781108.00), less than Tenax Therapeutics, Inc. (128.69M), greater than null (-79216590.00),

Build a custom stock screener for Diffusion Pharmaceuticals Inc. (DFFN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diffusion Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Diffusion Pharmaceuticals Inc. (DFFN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Diffusion Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.